Park Avenue Securities’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.4M Buy
54,714
+1,585
+3% +$421K 0.17% 102
2026
Q1
$5.82M Buy
+53,129
New +$7.57M 0.05% 285
2025
Q1
Sell
-3,775
Closed -$500K 1555
2024
Q4
$500K Buy
+3,775
New +$354K 0.01% 1076

Other funds holding ALAB

Park Avenue Securities's ALAB Position: Q2 2026 in Review

Park Avenue Securities increased its Astera Labs (ALAB) stake by 3% in Q2 2026, buying an estimated $421K and bringing the position to 54,714 shares worth $26.4M. The position accounts for 0.17% of the portfolio, ranked #102.

Park Avenue Securities first reported a position in ALAB in Q4 2024 and has held it in 3 quarters since. 982 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Park Avenue Securities held 54,714 shares of Astera Labs worth $26.4M as of Q2 2026.
  • Park Avenue Securities bought 1,585 Astera Labs shares in Q2 2026, an estimated $421K.
  • Astera Labs made up 0.17% of Park Avenue Securities's portfolio in Q2 2026, its #102 holding.
  • Park Avenue Securities first reported a position in Astera Labs in Q4 2024 and has held it in 3 quarters since.
  • 982 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.